Psoriasis Therapy Has Mixed Effects on Cardiovascular Risk Factors - Medpage Today

No reduction in vascular inflammation with apremilast but significant reduction in body fat

BOSTON -- An evaluation of a common psoriasis drug's effect on one cardiometabolic risk factor instead showed a favorable impact on a different one. The randomized trial showed that apremilast (Otez… [+4858 chars]

full article...